Halt™ Protease and Phosphatase Inhibitor Single-Use Cocktail (100X), 24 x 100 μL - Citations

Halt™ Protease and Phosphatase Inhibitor Single-Use Cocktail (100X), 24 x 100 μL - Citations

View additional product information for Halt™ Protease and Phosphatase Inhibitor Cocktail (100X) - Citations (78442, 78444, 78446, 78440)

Showing 7 product Citations

Citations & References
Abstract
Sex-dependent effect of sublethal copper concentrations on de novo cholesterol synthesis in astrocytes and their possible links to variations in cholesterol and amyloid precursor protein levels in neuronal membranes.
AuthorsZubillaga M,Tau J,Rosa D,Bellini MJ,Arnal N
JournalBiology of sex differences
PubMed ID38191520
BACKGROUND: Cholesterol (Cho) is an essential lipophilic molecule in cells; however, both its decrease and its increase may favor the development of neurological diseases such as Alzheimer's disease (AD). Although copper (Cu) is an essential trace metal for cells, the increased plasma concentration of its free form has been linked ... More
Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer.
AuthorsBhagwat SV,Mur C,Vandekopple M,Zhao B,Shen W,Marugán C,Capen A,Kindler L,Stephens JR,Huber L,Castanares MA,Garcia-Tapia D,Cohen JD,Bastian J,Mattioni B,Yuen E,Baker TK,Rodriguez Cruz V,Fei D,Manro JR,Pulliam N,Dowless MS,Ortiz Ruiz MJ,Yu C,Puca L,Klippel A,Bacchion F,Ismail-Khan R,Rodrik-Outmezguine V,Peng SB,Lallena MJ,Gong X,de Dios A
JournalCancer research
PubMed ID39652577
Targeting of the estrogen receptor (ER) by antiestrogens is the standard of care for patients with ER+ HER2- advanced/metastatic breast cancer. Although antiestrogens that degrade ERα (fulvestrant) or block estrogen production (aromatase inhibitors) have improved patient outcomes, clinically important challenges remain related to drug administration, limited bioavailability, lack of brain ... More
A PRMT5-ZNF326 axis mediates innate immune activation upon replication stress.
AuthorsHoang PM,Torre D,Jaynes P,Ho J,Mohammed K,Alvstad E,Lam WY,Khanchandani V,Lee JM,Toh CMC,Lee RX,Anbuselvan A,Lee S,Sebra RP,Martin J Walsh,Marazzi I,Kappei D,Guccione E,Jeyasekharan AD
JournalScience advances
PubMed ID38838142
DNA replication stress (RS) is a widespread phenomenon in carcinogenesis, causing genomic instability and extensive chromatin alterations. DNA damage leads to activation of innate immune signaling, but little is known about transcriptional regulators mediating such signaling upon RS. Using a chemical screen, we identified protein arginine methyltransferase 5 (PRMT5) as ... More
hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels.
AuthorsGibson A, Lewis AP, Affleck K, Aitken AJ, Meldrum E, Thompson N
JournalJ Biol Chem
PubMed ID15919655
'Proteins of the CLCA gene family have been proposed to mediate calcium-activated chloride currents. In this study, we used detailed bioinformatics analysis and found that no transmembrane domains are predicted in hCLCA1 or mCLCA3 (Gob-5). Further analysis suggested that they are globular proteins containing domains that are likely to be ... More
Quantitative PCR analysis of DNA, RNAs, and proteins in the same single cell.
AuthorsStåhlberg A, Thomsen C, Ruff D, Åman P
JournalClin Chem
PubMed ID23014600
The single cell represents the basic unit of all organisms. Most investigations have been performed on large cell populations, but understanding cell dynamics and heterogeneity requires single-cell analysis. Current methods for single-cell analysis generally can detect only one class of analytes. ... More
A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.
AuthorsShan W, Akinfenwa PY, Savannah KB, Kolomeyevskaya N, Laucirica R, Thomas DG, Odunsi K, Creighton CJ, Lev DC, Anderson ML
JournalClin Cancer Res
PubMed ID22535157
Uterine leiomyosarcoma (ULMS) is a poorly understood cancer with few effective treatments. This study explores the molecular events involved in ULMS with the goal of developing novel therapeutic strategies. ... More
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
AuthorsId Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F
JournalBMC Cancer
PubMed ID20565769
The proto-oncogene Src is an important non-receptor protein tyrosine kinase involved in signaling pathways that control cell adhesion, growth, migration and differentiation. It negatively regulates osteoblast activity, and, as such, its inhibition is a potential means to prevent bone loss. Dasatinib is a new dual Src/Bcr-Abl tyrosine kinase inhibitor initially ... More